Delivery Order SPE2DB20D2014-SPE2DB25FC28V
- Not listed
- The Defense Logistics Agency awarded a $22,429.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied to the place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a $36,703.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 19, 2025. This non-set-aside competitive award was issued on September 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $13,348.64 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This competitive, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The order will be fulfilled from the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,962.21 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels, and this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,603.55 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 4, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed on August 1, 2025, with the product to be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels and...
- The Defense Logistics Agency awarded a delivery order valued at $6,254.60 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 23, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order execution under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a $27,040.46 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,803.48 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's established capability...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC28VDelivery Order
The Defense Logistics Agency awarded a $1,926.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of June 24, 2025. This non-set-aside contract utilizes competitive procurement procedures and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be performed and shipped from the company's Conshohocken, Pennsylvania location. This delivery order supports the Defense Health Agency's pharmaceutical supply requirements through AmerisourceBergen's role as a prime vendor for the DLA Medical Supply Chain. Repatha is a specialty medication used for cholesterol management, reflecting the breadth of clinical therapeutics that AmerisourceBergen supplies to military healthcare systems. The company's extensive portfolio of federal medical procurement demonstrates its established capability to fulfill federal healthcare commodity needs across multiple therapeutic domains, including cardiovascular medications, diabetes treatments, and other specialized pharmaceuticals critical to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/23/25 |